Cat.#: ACPP-1238
| Despition | LIMK1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1208 | beta Catenin Blocking Peptide (AC1208) | 250 µg | inquiry |
| ACPP-1039 | Recombinant Human FGFR4 Protein (6×His Tag) (AC1039) | 50 µg | inquiry |
| ACPP-1830 | Human SDC1 Protein (AC1830) | 5 µg | inquiry |
| ACPP-1019 | Recombinant Human GPRC5A Protein (Fc Tag) (AC1019) | 50 µg | inquiry |
| ACPP-1707 | Human RAB5B Protein (AC1707) | 5 µg | inquiry |
| ACPP-1728 | Human Human C Peptide (Active) Protein (AC1728) | 100 µg | inquiry |
| ACPP-1537 | Human YY1 Protein (AC1537) | 5 µg | inquiry |
| ACPP-1150 | Synthetic Nanodisc Human TRPV1 Protein (AC1150) | 10 µg | inquiry |
| ACPP-1656 | Human MAPT Protein (AC1656) | 2 µg | inquiry |
| ACPP-1399 | Human LGALS7 Protein (AC1399) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.